SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEMAGEN DIAGNOSTICS (HMGN) -- Ignore unavailable to you. Want to Upgrade?


To: Dante Sinferno who wrote (1)11/13/1997 8:56:00 PM
From: Sandra  Read Replies (2) | Respond to of 98
 
Hi Rob,
Great thread! Looks good, cant wait to hear what Doug says or Jim. I have been thinking about buying MTON. I have many of the POW's also and I dont jump in and out either. I am down on some, and up on others! Really I have tried to adjust my portfolio to pick up as many POW"s as I can. Taking profits from companies I have held for years. I have no experience with TA, bought most of all my stocks doing my own DD without TA. Lately I can see how important TA is.......I missed MTON, and with Dougs TA on it I really feel now would be a great time to get in. HMGN really sounds intresting too, cant wait to see the comments..
Sandra



To: Dante Sinferno who wrote (1)12/2/1997 10:44:00 PM
From: Dante Sinferno  Read Replies (1) | Respond to of 98
 
Hemagen news update.....

Hemagen Obtains Clearance to Market Three Assays to
Diagnose Respitory Tract Disease :

biz.yahoo.com

HMGN closed at $2 1/4

Rob